Lovastatin: An HMG-CoA Reductase Inhibitor for Lowering Cholesterol
- 1 March 1989
- journal article
- review article
- Published by Elsevier in Medical Clinics of North America
- Vol. 73 (2) , 437-448
- https://doi.org/10.1016/s0025-7125(16)30681-2
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- LovastatinDrugs, 1988
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- Lovastatin therapy in nephrotic hyperlipidemia: Effects on lipoprotein metabolismKidney International, 1988
- Lovastatin for Lowering Cholesterol Levels in Non-Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1988
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- The effects of mevinolin and neomycin alone and in combination on plasma lipid and lipoprotein concentrations in type II hyperlipoproteinemiaAtherosclerosis, 1986
- Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemiaThe American Journal of Cardiology, 1986
- Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia.Journal of Clinical Investigation, 1984
- Rapid and substantial lowering of human serum cholesterol by mevinolin (MK-803), an inhibitor of hydroxymethylglutaryl-coenzyme a reductaseAtherosclerosis, 1982
- Regulation of Plasma Cholesterol by Lipoprotein ReceptorsScience, 1981